Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Infliximab
Remicade
Not routinely available
NICE (TA195)
29/09/2010
Indication
For adults with severe rheumatoid arthritis who have tried other disease-modifying antirheumatic drugs (DMARDs) but cannot tolerate them or they haven’t worked well enough.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
-
Comments
September 2010 - Added to the Additional List, for Specialist Use only. July 2019 (as per LJF) - Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines.
Link to Advice
Advice Published
25/08/2010